The post Coldplay’s Historic Tour Is Ending And Fans Are Celebrating appeared on BitcoinEthereumNews.com. Coldplay’s albums Parachutes, A Rush of Blood to the Head, Moon Music and Music of the Spheres return to the U.K. charts as the band wraps its historic tour. NASHVILLE, TENNESSEE – JULY 22: Chris Martin of Coldplay performs at Nissan Stadium on July 22, 2025 in Nashville, Tennessee. (Photo by Tibrina Hobson/Getty Images) Getty Images As Coldplay’s Music of the Spheres World Tour approaches its end, the band is finishing its historic run in the country where the musicians got their start. The group is in the middle of 10 scheduled dates at Wembley Stadium in London, which will conclude in early September. As the pop-rock outfit begins playing in the U.K. again, multiple albums return to the charts. In fact, every single Coldplay full-length that appears on any list in the nation mounts some sort of comeback. Parachutes Celebrates 25 Years With a Comeback Coldplay’s debut album Parachutes is the biggest winner this frame in terms of the number of charts it appears on. The project, which recently turned 25 years old, reappears on all four rankings on which it can be found. The set lives inside the top 40 on three sales rankings and narrowly sneaks back onto the downloads roster in a much lower position. A Rush of Blood to the Head Returns to the Top 40 Two years after Parachutes debuted, Coldplay released A Rush of Blood to the Head. That project nearly matches its predecessor in terms of the number of lists on which it finds space, as A Rush of Blood to the Head is a top 40 smash on all three rosters it returns to. This week, the full-length even manages to hit a new all-time high on both the Official Vinyl Albums and Official Albums Sales rankings, where it currently comes in… The post Coldplay’s Historic Tour Is Ending And Fans Are Celebrating appeared on BitcoinEthereumNews.com. Coldplay’s albums Parachutes, A Rush of Blood to the Head, Moon Music and Music of the Spheres return to the U.K. charts as the band wraps its historic tour. NASHVILLE, TENNESSEE – JULY 22: Chris Martin of Coldplay performs at Nissan Stadium on July 22, 2025 in Nashville, Tennessee. (Photo by Tibrina Hobson/Getty Images) Getty Images As Coldplay’s Music of the Spheres World Tour approaches its end, the band is finishing its historic run in the country where the musicians got their start. The group is in the middle of 10 scheduled dates at Wembley Stadium in London, which will conclude in early September. As the pop-rock outfit begins playing in the U.K. again, multiple albums return to the charts. In fact, every single Coldplay full-length that appears on any list in the nation mounts some sort of comeback. Parachutes Celebrates 25 Years With a Comeback Coldplay’s debut album Parachutes is the biggest winner this frame in terms of the number of charts it appears on. The project, which recently turned 25 years old, reappears on all four rankings on which it can be found. The set lives inside the top 40 on three sales rankings and narrowly sneaks back onto the downloads roster in a much lower position. A Rush of Blood to the Head Returns to the Top 40 Two years after Parachutes debuted, Coldplay released A Rush of Blood to the Head. That project nearly matches its predecessor in terms of the number of lists on which it finds space, as A Rush of Blood to the Head is a top 40 smash on all three rosters it returns to. This week, the full-length even manages to hit a new all-time high on both the Official Vinyl Albums and Official Albums Sales rankings, where it currently comes in…

Coldplay’s Historic Tour Is Ending And Fans Are Celebrating

Coldplay’s albums Parachutes, A Rush of Blood to the Head, Moon Music and Music of the Spheres return to the U.K. charts as the band wraps its historic tour. NASHVILLE, TENNESSEE – JULY 22: Chris Martin of Coldplay performs at Nissan Stadium on July 22, 2025 in Nashville, Tennessee. (Photo by Tibrina Hobson/Getty Images)

Getty Images

As Coldplay’s Music of the Spheres World Tour approaches its end, the band is finishing its historic run in the country where the musicians got their start. The group is in the middle of 10 scheduled dates at Wembley Stadium in London, which will conclude in early September.

As the pop-rock outfit begins playing in the U.K. again, multiple albums return to the charts. In fact, every single Coldplay full-length that appears on any list in the nation mounts some sort of comeback.

Parachutes Celebrates 25 Years With a Comeback

Coldplay’s debut album Parachutes is the biggest winner this frame in terms of the number of charts it appears on. The project, which recently turned 25 years old, reappears on all four rankings on which it can be found. The set lives inside the top 40 on three sales rankings and narrowly sneaks back onto the downloads roster in a much lower position.

A Rush of Blood to the Head Returns to the Top 40

Two years after Parachutes debuted, Coldplay released A Rush of Blood to the Head. That project nearly matches its predecessor in terms of the number of lists on which it finds space, as A Rush of Blood to the Head is a top 40 smash on all three rosters it returns to.

This week, the full-length even manages to hit a new all-time high on both the Official Vinyl Albums and Official Albums Sales rankings, where it currently comes in at Nos. 17 and 40, respectively.

Amazingly, despite being one of the better-selling projects of the past quarter century in the U.K., A Rush of Blood to the Head only just now becomes a top 40 success on the Official Albums Sales tally for the first time.

Viva La Vida Joins Coldplay’s Chart Surge

Viva La Vida or Death and All His Friends joins A Rush of Blood to the Head on the same three rankings, but its journey to them is quite different. The experimental project reenters the Official Physical Albums chart at No. 83. This time around, the blockbuster also debuts at No. 33 on the Official Vinyl Albums ranking and No. 88 on the Official Albums Sales tally.

Moon Music and Music of the Spheres

Two other titles by Coldplay – Moon Music and Music of the Spheres – both find their way once again to the Official Album Downloads chart, and they manage to sit near one another. Moon Music is the bigger winner, as it’s back at No. 72, while Music of the Spheres reenters at No. 79. Those two full-lengths are currently being promoted on Coldplay’s trek, but fans in the U.K. clearly still prefer the group’s older material.

Source: https://www.forbes.com/sites/hughmcintyre/2025/08/28/coldplays-historic-tour-is-ending-and-fans-are-celebrating/

Market Opportunity
Sidekick Logo
Sidekick Price(K)
$0.005752
$0.005752$0.005752
+37.90%
USD
Sidekick (K) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26